{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T02:07:24Z","timestamp":1779070044236,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Independence Research Fund Denmark","award":["1057-00018b"],"award-info":[{"award-number":["1057-00018b"]}]},{"DOI":"10.13039\/100015459","name":"Danish Cancer Society Research Center","doi-asserted-by":"publisher","award":["R351-A20092"],"award-info":[{"award-number":["R351-A20092"]}],"id":[{"id":"10.13039\/100015459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04837-5","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:04:47Z","timestamp":1775775887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating DNA methylation markers and extended HPV genotyping in first-void urine for detecting high-grade cervical lesions in HPV-positive women: a cross-sectional study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6285-6694","authenticated-orcid":false,"given":"Mette","family":"Tranberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severien","family":"Van Keer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albertus T.","family":"Hesselink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikke","family":"Br\u00f8ndum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunsen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line Winther","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Bor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen Omann","family":"Binderup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Blach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Vorsters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renske","family":"Steenbergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"9","key":"4837_CR1","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/bjc.2016.290","volume":"115","author":"R Landy","year":"2016","unstructured":"Landy R, Pesola F, Casta\u00f1\u00f3n A, Sasieni P. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study. Br J Cancer. 2016;115(9):1140\u20136.","journal-title":"Br J Cancer"},{"key":"4837_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106900","volume":"154","author":"B Serrano","year":"2022","unstructured":"Serrano B, Ib\u00e1\u00f1ez R, Robles C, Peremiquel-Trillas P, de Sanjos\u00e9 S, Bruni L. Worldwide use of HPV self-sampling for cervical cancer screening. Prev Med. 2022;154:106900.","journal-title":"Prev Med"},{"issue":"9916","key":"4837_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJF, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524\u201332.","journal-title":"Lancet"},{"key":"4837_CR4","doi-asserted-by":"crossref","unstructured":"Huntington S, Smith JS, Nuttall D, Polokaova A, Smith PM, Hamlyn-Williams C, et al. Evidence from Europe on implementation, participation and performance of self-collection for cervical cancer screening.\u00a0Future Oncol. 2026;22(5):583\u201394.","DOI":"10.1080\/14796694.2024.2409625"},{"issue":"1","key":"4837_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12916-025-04149-0","volume":"23","author":"M Tranberg","year":"2025","unstructured":"Tranberg M, Van Keer S, Jensen JS, N\u00f8rgaard P, Gustafson LW, Hammer A, et al. High-risk human papillomavirus testing in first-void urine as a novel and non-invasive cervical cancer screening modality-a Danish diagnostic test accuracy study. BMC Med. 2025;23(1):327.","journal-title":"BMC Med"},{"issue":"3","key":"4837_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ygyno.2021.06.010","volume":"162","author":"S Van Keer","year":"2021","unstructured":"Van Keer S, Peeters E, Vanden Broeck D, De Sutter P, Donders G, Doyen J, et al. Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol. Gynecol Oncol. 2021;162(3):575\u201383.","journal-title":"Gynecol Oncol"},{"key":"4837_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2022.105271","volume":"155","author":"S Van Keer","year":"2022","unstructured":"Van Keer S, Latsuzbaia A, Vanden Broeck D, De Sutter P, Donders G, Doyen J, et al. Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study. J Clin Virol. 2022;155:105271.","journal-title":"J Clin Virol"},{"issue":"5","key":"4837_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/annonc\/mdt538","volume":"25","author":"MG Dijkstra","year":"2014","unstructured":"Dijkstra MG, Snijders PJ, Arbyn M, Rijkaart DC, Berkhof J, Meijer CJ. Cervical cancer screening: on the way to a shift from cytology to full molecular screening. Ann Oncol. 2014;25(5):927\u201335.","journal-title":"Ann Oncol"},{"key":"4837_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2017.06.036","volume":"216","author":"S Van Keer","year":"2017","unstructured":"Van Keer S, Pattyn J, Tjalma WAA, Van Ostade X, Ieven M, Van Damme P, et al. First-void urine: a potential biomarker source for triage of high-risk human papillomavirus infected women. Eur J Obstet Gynecol Reprod Biol. 2017;216:1\u201311.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4837_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4823","volume":"363","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;363:k4823.","journal-title":"BMJ"},{"key":"4837_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2024.102678","volume":"41","author":"FR Burdier","year":"2024","unstructured":"Burdier FR, Waheed DE, Nedjai B, Steenbergen RDM, Poljak M, Baay M, et al. DNA methylation as a triage tool for cervical cancer screening - a meeting report. Prev Med Rep. 2024;41:102678.","journal-title":"Prev Med Rep"},{"key":"4837_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2023.04.022","volume":"174","author":"MH Stoler","year":"2023","unstructured":"Stoler MH, Parvu V, Yanson K, Andrews J, Vaughan L. Risk stratification of HPV-positive results using extended genotyping and cytology: data from the baseline phase of the Onclarity trial. Gynecol Oncol. 2023;174:68\u201375.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"4837_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/LGT.0000000000000494","volume":"24","author":"JH Bonde","year":"2020","unstructured":"Bonde JH, Sandri MT, Gary DS, Andrews JC. Clinical utility of human papillomavirus genotyping in cervical cancer screening: a systematic review. J Low Genit Tract Dis. 2020;24(1):1\u201313.","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"4837_CR14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/ijc.32291","volume":"145","author":"J Bonde","year":"2019","unstructured":"Bonde J, Bottari F, Parvu V, Pedersen H, Yanson K, Iacobone AD, et al. Bayesian analysis of baseline risk of CIN2 and \u2265CIN3 by HPV genotype in a European referral cohort. Int J Cancer. 2019;145(4):1033\u201341.","journal-title":"Int J Cancer"},{"issue":"6","key":"4837_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrc3728","volume":"14","author":"RD Steenbergen","year":"2014","unstructured":"Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14(6):395\u2013405.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"4837_CR16","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/1878-0261.13628","volume":"19","author":"BMM Wever","year":"2024","unstructured":"Wever BMM, Steenbergen RDM. Unlocking the potential of tumor-derived DNA in urine for cancer detection: methodological challenges and opportunities. Mol Oncol. 2024;19(7):1918\u201334.","journal-title":"Mol Oncol"},{"issue":"3","key":"4837_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/cancers13030535","volume":"13","author":"AE Hentschel","year":"2021","unstructured":"Hentschel AE, van den Helder R, van Trommel NE, van Splunter AP, van Boerdonk RAA, van Gent M, et al. The Origin of Tumor DNA in Urine of Urogenital Cancer Patients: Local Shedding and Transrenal Excretion. Cancers (Basel). 2021;13(3):535.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"4837_CR18","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41416-019-0593-4","volume":"121","author":"H Kelly","year":"2019","unstructured":"Kelly H, Benavente Y, Pavon MA, De Sanjose S, Mayaud P, Lorincz AT. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis. Br J Cancer. 2019;121(11):954\u201365.","journal-title":"Br J Cancer"},{"key":"4837_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ebiom.2019.10.053","volume":"50","author":"SJ Bowden","year":"2019","unstructured":"Bowden SJ, Kalliala I, Veroniki AA, Arbyn M, Mitra A, Lathouras K, et al. The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: a systematic review and meta-analysis. EBioMedicine. 2019;50:246\u201359.","journal-title":"EBioMedicine"},{"issue":"1","key":"4837_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01537-2","volume":"15","author":"S Salta","year":"2023","unstructured":"Salta S, Lobo J, Magalh\u00e3es B, Henrique R, Jer\u00f3nimo C. DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis. Clin Epigenetics. 2023;15(1):125.","journal-title":"Clin Epigenetics"},{"key":"4837_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2024.200308","volume":"19","author":"S Dick","year":"2025","unstructured":"Dick S, Heideman DAM, Berkhof J, Steenbergen RDM, Bleeker MCG. Clinical indications for host-cell DNA methylation markers in cervical screening and management of cervical intraepithelial neoplasia: a review. Tumour Virus Res. 2025;19:200308.","journal-title":"Tumour Virus Res"},{"issue":"1","key":"4837_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-024-00623-1","volume":"19","author":"EG Sumiec","year":"2024","unstructured":"Sumiec EG, Yim ZY, Mohy-Eldin H, Nedjai B. The current state of DNA methylation biomarkers in self-collected liquid biopsies for the early detection of cervical cancer: a literature review. Infect Agent Cancer. 2024;19(1):62.","journal-title":"Infect Agent Cancer"},{"issue":"12","key":"4837_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70739","volume":"97","author":"H Liu","year":"2025","unstructured":"Liu H, Zhou J, Xiao Y, Zheng Y, Yu L, Dong D, et al. High-throughput targeted sequencing identifies an HPV methylation panel for detecting cervical lesion progression. J Med Virol. 2025;97(12):e70739.","journal-title":"J Med Virol"},{"issue":"26","key":"4837_CR24","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1200\/JCO.21.02433","volume":"40","author":"WW Kremer","year":"2022","unstructured":"Kremer WW, Dick S, Heideman DAM, Steenbergen RDM, Bleeker MCG, Verhoeve HR, et al. Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4\/miR124-2 DNA Methylation (CONCERVE Study). J Clin Oncol. 2022;40(26):3037\u201346.","journal-title":"J Clin Oncol"},{"issue":"12","key":"4837_CR25","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1093\/cid\/ciz677","volume":"70","author":"K Louvanto","year":"2020","unstructured":"Louvanto K, Aro K, Nedjai B, B\u00fctzow R, Jakobsson M, Kalliala I, et al. Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia. Clin Infect Dis. 2020;70(12):2582\u201390.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4837_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ijc.33815","volume":"150","author":"C Banila","year":"2022","unstructured":"Banila C, Lorincz AT, Scibior-Bentkowska D, Clifford GM, Kumbi B, Beyene D, et al. Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study. Int J Cancer. 2022;150(2):290\u2013302.","journal-title":"Int J Cancer"},{"issue":"4","key":"4837_CR27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/ijc.32614","volume":"147","author":"FJ Vink","year":"2020","unstructured":"Vink FJ, Meijer C, Clifford GM, Poljak M, O\u0161trbenk A, Petry KU, et al. FAM19A4\/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study. Int J Cancer. 2020;147(4):1215\u201321.","journal-title":"Int J Cancer"},{"issue":"6","key":"4837_CR28","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1158\/1055-9965.EPI-06-0694","volume":"16","author":"Q Feng","year":"2007","unstructured":"Feng Q, Hawes SE, Stern JE, Dem A, Sow PS, Dembele B, et al. Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1178\u201384.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"4837_CR29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1158\/1940-6207.CAPR-16-0138","volume":"9","author":"R Guerrero-Preston","year":"2016","unstructured":"Guerrero-Preston R, Valle BL, Jedlicka A, Turaga N, Folawiyo O, Pirini F, et al. Molecular triage of premalignant lesions in liquid-based cervical cytology and circulating cell-free DNA from urine, using a panel of methylated human papilloma virus and host genes. Cancer Prev Res (Phila). 2016;9(12):915\u201324.","journal-title":"Cancer Prev Res (Phila)"},{"key":"4837_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.21037\/tcr.2017.01.41","volume":"6","author":"R Hoffstetter","year":"2017","unstructured":"Hoffstetter R, Riquelme I, Andana A, Ili CG, Buchegger K, Vargas H, et al. Evaluation of DNA methylation in promoter regions of SFRP4 and ZAR1 in urine and plasma of women with cervical lesions. Transl Cancer Res. 2017;6:157\u201368.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"4837_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87329-1","volume":"11","author":"S Van Keer","year":"2021","unstructured":"Van Keer S, van Splunter AP, Pattyn J, De Smet A, Herzog SA, Van Ostade X, et al. Triage of human papillomavirus infected women by methylation analysis in first-void urine. Sci Rep. 2021;11(1):7862.","journal-title":"Sci Rep"},{"key":"4837_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2020.100193","volume":"9","author":"R van den Helder","year":"2020","unstructured":"van den Helder R, van Trommel NE, van Splunter AP, Lissenberg-Witte BI, Bleeker MCG, Steenbergen RDM. Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection. Papillomavirus Res. 2020;9:100193.","journal-title":"Papillomavirus Res"},{"key":"4837_CR33","doi-asserted-by":"crossref","unstructured":"Van Keer S, van den Helder R, T\u00e9blick L, De Smet A, Donders G, Weyers S, et al. Clinical performance of ASCL1\/LHX8 DNA methylation on first-void urine to screen for cervical cancer. Commun Med (Lond). 2026. Epub ahead of print.","DOI":"10.1038\/s43856-026-01512-x"},{"issue":"10","key":"4837_CR34","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-21-3710","volume":"28","author":"R van den Helder","year":"2022","unstructured":"van den Helder R, Steenbergen RDM, van Splunter AP, Mom CH, Tjiong MY, Martin I, et al. Hpv and DNA methylation testing in urine for cervical intraepithelial neoplasia and cervical cancer detection. Clin Cancer Res. 2022;28(10):2061\u20138.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4837_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41416-023-02277-z","volume":"129","author":"L Verhoef","year":"2023","unstructured":"Verhoef L, Bleeker MCG, Polman N, Steenbergen RDM, Ebisch RMF, Melchers WJG, et al. Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening. Br J Cancer. 2023;129(1):104\u201311.","journal-title":"Br J Cancer"},{"issue":"14","key":"4837_CR36","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1158\/1078-0432.CCR-17-3615","volume":"24","author":"W Verlaat","year":"2018","unstructured":"Verlaat W, Snoek BC, Heideman DAM, Wilting SM, Snijders PJF, Novianti PW, et al. Identification and validation of a 3-gene methylation classifier for HPV-based cervical screening on self-samples. Clin Cancer Res. 2018;24(14):3456\u201364.","journal-title":"Clin Cancer Res"},{"issue":"18","key":"4837_CR37","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2217\/epi-2019-0331","volume":"12","author":"S Dick","year":"2020","unstructured":"Dick S, Verhoef L, De Strooper LM, Cioc\u0103nea-Teodorescu I, Wisman GBA, Meijer CJ, et al. Evaluation of six methylation markers derived from genome-wide screens for detection of cervical precancer and cancer. Epigenomics. 2020;12(18):1569\u201378.","journal-title":"Epigenomics"},{"issue":"3","key":"4837_CR38","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ijc.33820","volume":"150","author":"L Verhoef","year":"2022","unstructured":"Verhoef L, Bleeker MCG, Polman N, Steenbergen RDM, Meijer C, Melchers WJG, et al. Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort. Int J Cancer. 2022;150(3):440\u20139.","journal-title":"Int J Cancer"},{"key":"4837_CR39","unstructured":"Noehr DF KH NK, Fuglsang K, Hansen K, Petersen LK et al. Diagnosis, management, and follow-up of cervical dysplasia guidelines. In Danish [Udredning, behandling og kontrol of cervical dysplasi). DSOG retningslinje (in Danish only). 2012."},{"key":"4837_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2023.105638","volume":"170","author":"A O\u0161trbenk Valen\u010dak","year":"2024","unstructured":"O\u0161trbenk Valen\u010dak A, Cuschieri K, Connor L, Zore A, Smrkolj \u0160, Poljak M. Allplex HPV HR detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening. J Clin Virol. 2024;170:105638.","journal-title":"J Clin Virol"},{"issue":"6","key":"4837_CR41","first-page":"485","volume":"12","author":"H Richardson","year":"2003","unstructured":"Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev. 2003;12(6):485\u201390.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4837_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CLEP.S9908","volume":"2","author":"R Erichsen","year":"2010","unstructured":"Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol. 2010;2:51\u20136.","journal-title":"Clin Epidemiol"},{"issue":"4","key":"4837_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22854","volume":"33","author":"A Floore","year":"2019","unstructured":"Floore A, Hesselink A, O\u0161trbenk A, Alcaniz E, Rothe B, Pedersen H, et al. Intra- and inter-laboratory agreement of the FAM19A4\/mir124-2 methylation test: Results from an international study. J Clin Lab Anal. 2019;33(4):e22854.","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"4837_CR44","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101\u20138.","journal-title":"Nat Protoc"},{"issue":"10","key":"4837_CR45","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","volume":"136","author":"TM Darragh","year":"2012","unstructured":"Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med. 2012;136(10):1266\u201397.","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"4837_CR46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/15592294.2018.1507197","volume":"13","author":"W Verlaat","year":"2018","unstructured":"Verlaat W, Van Leeuwen RW, Novianti PW, Schuuring E, Meijer C, Van Der Zee AGJ, et al. Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer. Epigenetics. 2018;13(7):769\u201378.","journal-title":"Epigenetics"},{"key":"4837_CR47","unstructured":"S.L. HDR. Applied logistic regression, in: Wiley Series in Probability and Statistics: John Wiley & Sons, Inc, 2013."},{"key":"4837_CR48","unstructured":"NSLS. Danish cervical cancer screening guidelines for triage of HPV-positive women aged 30 to 59 years [Flowcharts shown in Danish only] 2019 [Available from: https:\/\/www.regioner.dk\/media\/12094\/bilag-1-3-nsls-moede-27-mar-2019.pdf."},{"issue":"2","key":"4837_CR49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"1","key":"4837_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00958-7","volume":"12","author":"R van den Helder","year":"2020","unstructured":"van den Helder R, Wever BMM, van Trommel NE, van Splunter AP, Mom CH, Kasius JC, et al. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine. Clin Epigenetics. 2020;12(1):165.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"4837_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39275-2","volume":"9","author":"BC Snoek","year":"2019","unstructured":"Snoek BC, Splunter APV, Bleeker MCG, Ruiten MCV, Heideman DAM, Rurup WF, et al. Cervical cancer detection by DNA methylation analysis in urine. Sci Rep. 2019;9(1):3088.","journal-title":"Sci Rep"},{"issue":"1","key":"4837_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01116-9","volume":"14","author":"JE Barrett","year":"2022","unstructured":"Barrett JE, Sundstr\u00f6m K, Jones A, Evans I, Wang J, Herzog C, et al. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer. Genome Med. 2022;14(1):116.","journal-title":"Genome Med"},{"issue":"3","key":"4837_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091905","volume":"9","author":"A Hansel","year":"2014","unstructured":"Hansel A, Steinbach D, Greinke C, Schmitz M, Eiselt J, Scheungraber C, et al. A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women. PLoS ONE. 2014;9(3):e91905.","journal-title":"PLoS ONE"},{"issue":"1","key":"4837_CR54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ijc.31787","volume":"144","author":"A Leeman","year":"2019","unstructured":"Leeman A, Del Pino M, Marimon L, Torn\u00e9 A, Ordi J, Ter Harmsel B, et al. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population. Int J Cancer. 2019;144(1):160\u20138.","journal-title":"Int J Cancer"},{"issue":"3","key":"4837_CR55","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1093\/cid\/ciac433","volume":"76","author":"FJ Vink","year":"2023","unstructured":"Vink FJ, Meijer C, Hesselink AT, Floore AN, Lissenberg-Witte BI, Bonde JH, et al. FAM19A4\/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16\/18 Genotyping in HPV-Positive Women Under the Age of 30 Years. Clin Infect Dis. 2023;76(3):e827\u201334.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4837_CR56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","volume":"25","author":"DL Loopik","year":"2021","unstructured":"Loopik DL, Bentley HA, Eijgenraam MN, IntHout J, Bekkers RLM, Bentley JR. The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: a systematic review and meta-analysis. J Low Genit Tract Dis. 2021;25(3):221\u201331.","journal-title":"J Low Genit Tract Dis"},{"key":"4837_CR57","doi-asserted-by":"crossref","unstructured":"Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, C\u00e1rdenas J, Hern\u00e1ndes, et al. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018;360:k499.","DOI":"10.1136\/bmj.k499"},{"issue":"9","key":"4837_CR58","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/ijc.35044","volume":"155","author":"K Louvanto","year":"2024","unstructured":"Louvanto K, Verhoef L, Pimenoff V, Eriksson T, Lepp\u00e4l\u00e4 S, Lagheden C, et al. Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions. Int J Cancer. 2024;155(9):1549\u201357.","journal-title":"Int J Cancer"},{"issue":"10","key":"4837_CR59","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1080\/15592294.2021.1992911","volume":"17","author":"L Verhoef","year":"2022","unstructured":"Verhoef L, Floore AN, Doorn S, Cuschieri K, Bhatia R, Hesselink AT, et al. Direct bisulphite conversion of cervical samples for DNA methylation analysis. Epigenetics. 2022;17(10):1173\u20139.","journal-title":"Epigenetics"},{"issue":"3","key":"4837_CR60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.slast.2021.12.002","volume":"27","author":"A Stark","year":"2022","unstructured":"Stark A, Pisanic TR 2nd, Herman JG, Wang TH. High-throughput sample processing for methylation analysis in an automated, enclosed environment. SLAS Technol. 2022;27(3):172\u20139.","journal-title":"SLAS Technol"},{"key":"4837_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.111227","volume":"166","author":"AR Brentnall","year":"2024","unstructured":"Brentnall AR, Cuschieri K, Sargent A, Berkhof J, Rebolj M. Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening. J Clin Epidemiol. 2024;166:111227.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04837-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T02:02:18Z","timestamp":1779069738000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04837-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4837"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04837-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8249226\/v1","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was listed in the record of processing activities for research projects in the Central Denmark Region (j.no. 1-16-02-313-21) and approved by the Ethics Committee in the Central Denmark Region (j. no: 1-10-72-246-21). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Seegene sponsors the Allplex HR HPV assays for the study. According to the contract between Seegene and the University Research Clinic for Cancer Screening and Dept. of Pathology, Randers Regional Hospital, Seegene had no influence on the scientific process and no editorial rights pertaining to this manuscript. The authors retained the right to submit the manuscript. MT have participated in other studies with HPV test kits sponsored by Roche. MT has received honoraria fee from Roche Diagnostics and AstraZeneca for lectures on HPV self-sampling and HPV triage-methods, respectively. SVK is supported by a senior postdoctoral fellowship of the Research Foundation \u2013 Flanders (grant no: 12AHX26N). LWG and AH: Have outside this project, received free-of-charge test kits from Roche Diagnostics and AH has received honoraria fee from Exeltis. PN, RB, PB, KOB, and CB: No competing interests. ATH is an employee of Self-screen BV. AV is co-founder of and former board member of Novosanis (Subsidiary of OraSure Technologies Inc, Wijnegem, Belgium), a spin-off company of the University of Antwerp, and was minority shareholder until January 2019. RS is a minority shareholder of Self-screen BV and received consultancy fees form AstraZeneca paid to her institution.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}